Description

The Health Anxiety Inventory (HAI-18) is a widely recognized psychometric instrument developed to assess the severity of health anxiety, including cognitive, emotional, and behavioral characteristics associated with excessive concern about health and illness. Developed by Salkovskis and colleagues, the HAI-18 provides a comprehensive evaluation of health-related worries regardless of whether an individual has an existing medical condition.

The instrument measures how individuals perceive, interpret, and respond to bodily sensations, physical symptoms, and the possibility of developing a serious illness. It evaluates maladaptive beliefs about health, excessive vigilance toward bodily changes, fear of illness, reassurance-seeking behaviors, and avoidance strategies that are commonly associated with Illness Anxiety Disorder and related anxiety conditions.

Unlike symptom-based medical assessments, the HAI-18 focuses primarily on psychological responses to perceived health threats, making it particularly useful for distinguishing excessive health anxiety from genuine physical disease.

The HAI-18 is extensively used in clinical psychology, psychiatry, behavioral medicine, health psychology, psychosomatic medicine, primary healthcare, and clinical research, where the assessment of health-related anxiety is essential for diagnosis, treatment planning, and outcome evaluation.

Data Analysis and Applications

Data obtained from the HAI-18 are analyzed using established psychometric and statistical procedures to evaluate the reliability and validity of the instrument. Internal consistency is commonly assessed using Cronbach’s alpha, while the factorial structure may be examined through Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).

Total scores provide an overall measure of health anxiety and can be examined in relation to numerous psychological and clinical variables, including:

  • generalized anxiety;
  • depressive symptoms;
  • psychological distress;
  • somatic symptom severity;
  • healthcare utilization;
  • reassurance-seeking behaviors;
  • quality of life;
  • illness-related beliefs and cognitive biases.

The HAI-18 is widely used to:

  • identify elevated levels of health anxiety;
  • assess the severity of illness-related fears;
  • monitor treatment outcomes during psychological interventions;
  • evaluate cognitive-behavioral therapy and other mental health treatments;
  • support differential assessment of anxiety disorders;
  • facilitate research on illness anxiety, hypochondriasis, and health-related cognition.

Its strong psychometric properties make the HAI-18 an important assessment tool for both clinical practice and scientific investigation.

Purpose

The primary purpose of the Health Anxiety Inventory (HAI-18) is to provide a reliable and valid assessment of health-related anxiety and maladaptive beliefs concerning illness and physical health.

More specifically, the instrument aims to:

  • evaluate excessive worry about health and illness;
  • identify dysfunctional interpretations of bodily sensations;
  • assess reassurance-seeking and avoidance behaviors associated with health anxiety;
  • support clinical assessment and individualized treatment planning;
  • evaluate psychological interventions targeting illness anxiety;
  • facilitate research on health anxiety, cognitive processes, and psychosomatic disorders.

By identifying cognitive, emotional, and behavioral aspects of health anxiety, the HAI-18 contributes to a deeper understanding of illness-related concerns and supports evidence-based interventions designed to improve psychological well-being and adaptive health behaviors.

Scoring

The HAI-18 consists of 18 items, each offering four ordered response options that reflect increasing levels of health-related concern or distress.

Responses are scored from 0 to 3, according to the developers’ scoring guidelines:

  • 0 = Minimal or no health anxiety
  • 1 = Mild health-related concern
  • 2 = Moderate health anxiety
  • 3 = Severe health anxiety

The total score is calculated by summing the scores across all 18 items. Higher total scores indicate greater health anxiety, stronger illness-related fears, increased maladaptive health beliefs, and a greater likelihood of clinically significant illness anxiety requiring further psychological evaluation.

The HAI-18 may also be used to monitor changes in health anxiety over time, making it particularly useful for evaluating treatment effectiveness in both clinical practice and research settings.

References

Salkovskis, P. M., Rimes, K. A., Warwick, H. M. C., & Clark, D. M. (2002). The Health Anxiety Inventory: Development and Validation of Scales for the Measurement of Health Anxiety and Hypochondriasis. Psychological Medicine, 32(5), 843–853.

Salkovskis, P. M. (1991). The Importance of Behaviour in the Maintenance of Health Anxiety: A Review and Some Theoretical Considerations. Behaviour Research and Therapy, 29(6), 367–380.

Warwick, H. M. C., & Salkovskis, P. M. (1990). Health Anxiety Inventory (HAI): Development and Clinical Applications.

Scale-Description

Hospital Anxiety and Depression Scale (HADS-14)

Description

The Hospital Anxiety and Depression Scale (HADS-14) is one of the most widely used psychometric screening instruments for assessing symptoms of anxiety and depression among individuals receiving medical care. Developed by Zigmond and Snaith (1983), the questionnaire was specifically designed to identify emotional distress in patients with physical illnesses while minimizing the influence of somatic symptoms that may be attributable to underlying medical conditions rather than psychological disorders.

The HADS consists of 14 self-report items, divided into two independent subscales:

  • HADS-A (Anxiety) – 7 items
  • HADS-D (Depression) – 7 items

Unlike many traditional depression and anxiety questionnaires, the HADS focuses primarily on the psychological and cognitive manifestations of emotional distress, excluding physical symptoms such as fatigue, sleep disturbance, dizziness, or appetite changes. This makes the instrument particularly suitable for use in hospital settings and among individuals with chronic medical conditions.

Today, the HADS is extensively used in clinical psychology, psychiatry, oncology, cardiology, neurology, primary healthcare, rehabilitation, and psychosomatic medicine, as well as in clinical trials and epidemiological research investigating mental health and health-related quality of life.

Data Analysis and Applications

Responses obtained from the HADS are analyzed using well-established psychometric and statistical procedures to ensure the reliability and validity of the instrument. Internal consistency is commonly evaluated using Cronbach’s alpha, while the questionnaire’s dimensional structure may be examined using Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).

Separate scores are calculated for the Anxiety and Depression subscales, allowing clinicians and researchers to evaluate each construct independently. The HADS is commonly used to:

  • screen for symptoms of anxiety and depression in medical populations;
  • monitor psychological status during treatment and rehabilitation;
  • evaluate the effectiveness of psychological or pharmacological interventions;
  • investigate associations between emotional distress, disease severity, treatment adherence, and quality of life;
  • support clinical and epidemiological research in healthcare settings.

Because of its brevity, ease of administration, and strong psychometric performance, the HADS remains one of the most frequently employed screening instruments in both clinical practice and scientific research.

Purpose

The primary purpose of the Hospital Anxiety and Depression Scale (HADS-14) is to provide a reliable and valid assessment of anxiety and depressive symptoms in individuals with medical illnesses.

More specifically, the instrument aims to:

  • identify patients experiencing clinically relevant emotional distress;
  • distinguish symptoms of anxiety from symptoms of depression;
  • monitor changes in psychological well-being over time;
  • evaluate treatment outcomes in clinical and research settings;
  • support healthcare professionals in identifying individuals who may benefit from further psychological assessment.

It is important to note that the HADS is a screening instrument and should not be used as a stand-alone diagnostic tool. Results should always be interpreted alongside a comprehensive clinical evaluation.

Scoring

The HADS-14 consists of 14 items, each scored on a 4-point response scale (0–3).

The questionnaire comprises two independent subscales:

  • Anxiety (HADS-A): Items 1, 3, 5, 7, 9, 11, and 13
  • Depression (HADS-D): Items 2, 4, 6, 8, 10, 12, and 14

Each subscale produces a score ranging from 0 to 21.

The most commonly used interpretation is:

  • 0–7: Normal
  • 8–10: Borderline abnormal (possible case)
  • 11–21: Abnormal (probable clinically significant anxiety or depression)

Higher scores indicate greater severity of anxiety or depressive symptoms. Since anxiety and depression are measured independently, the two subscales should always be interpreted separately.

References

Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.

Herrmann, C. (1997). International Experiences with the Hospital Anxiety and Depression Scale: A Review of Validation Data and Clinical Results. Journal of Psychosomatic Research, 42(1), 17–41.

Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The Validity of the Hospital Anxiety and Depression Scale: An Updated Literature Review. Journal of Psychosomatic Research, 52(2), 69–77.